ASTX030

· Taiho Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ASTX030, covering 2025-12-03 to 2025-12-03. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Trial of ASTX030 in Patients With Myelodysplastic Syndrome [Phase 1]